Asthma and COPD
Bronchial Asthma and Chronic Obstructive Pulmonary Disease are obstructive pneumonic sicknesses that influenced a large number of people everywhere throughout the world. Chronic Obstructive Pulmonary Disease (COPD) is a group of pulmonary diseases that block air stream in the lungs. Asthma is a chronic disease noticeable by spasms of bronchi, due to inflamed and narrowed airways in the lungs. Asthma causes difficulty in breathing that often results from an allergic reaction. There is large evidence that treatment with anti-inflammatory drugs reduces morbidity and mortality in asthma. Inhaled corticosteroids appear to have a place in the management of severe chronic obstructive pulmonary disease, perhaps by decreasing the frequency of exacerbations. Lung Conferences envelop the fields of asthma and COPD which have important similarities and differences. Asthma and COPD are chronic inflammatory diseases that include the little airway routes and cause airflow impediment, both result from gene environment communications and both are typically characterized by mucus and bronchoconstriction.
Related Conference of Asthma and COPD
14th International Conference on COPD Clinical Trials & Lung Care Advances
18th International Conference on Chronic Obstructive Pulmonary Disease
16th International Conference on Pulmonary & Respiratory Medicine
Asthma and COPD Conference Speakers
Recommended Sessions
- Asthma and COPD
- Chronic Obstructive Pulmonary Disease
- Co-Morbidities of COPD
- COPD and Cardiovascular Diseases
- COPD Complications
- COPD Exacerbations
- COPD Pathogenesis
- COPD Therapeutics
- COPD: Sign and Symptoms
- Depression and anxiety in COPD
- Drug Discovery of COPD
- Epidemiology of COPD
- Genetic risk factor of COPD
- Lung cancer
- Pathophysiology of COPD
- Pediatric Pulmonary, Critical care and Sleep
- Pulmonary diseases-treatment and therapies
- Pulmonary Hypertension
- Self-Management and Prevention of COPD
- Types of COPD
Related Journals
Are you interested in
- Advanced Lung Imaging - PULMONOLOGY 2026 (France)
- AI in Pulmonary Diagnostics - PULMONOLOGY 2026 (France)
- Asthama - Copd 2026 (France)
- Chronic Bronchitis - Copd 2026 (France)
- Chronic Obstructive Pulmonary Disease (COPD) - Copd 2026 (France)
- COPD Innovations - PULMONOLOGY 2026 (France)
- Coronavirus (COVID-19) - Copd 2026 (France)
- Critical Care Pulmonology - PULMONOLOGY 2026 (France)
- Cystic Fibrosis - Copd 2026 (France)
- Digital Respiratory Health - PULMONOLOGY 2026 (France)
- Emphysema - Copd 2026 (France)
- Environmental Lung Diseases - PULMONOLOGY 2026 (France)
- Interstitial Lung Diseases - PULMONOLOGY 2026 (France)
- Interventional pulmonology - Copd 2026 (France)
- Interventional Pulmonology - PULMONOLOGY 2026 (France)
- Lung Cancer - Copd 2026 (France)
- Lung Cancer Biomarkers - PULMONOLOGY 2026 (France)
- Mechanical Ventilation Strategies - PULMONOLOGY 2026 (France)
- Pediatric Pulmonology - PULMONOLOGY 2026 (France)
- Pneumonia - Copd 2026 (France)
- Precision Respiratory Medicine - PULMONOLOGY 2026 (France)
- Pulmonary Arterial Hypertension - Copd 2026 (France)
- Pulmonary Fibrosis Research - PULMONOLOGY 2026 (France)
- Pulmonary Hypertension - PULMONOLOGY 2026 (France)
- Pulmonary Rehabilitation - PULMONOLOGY 2026 (France)
- Respiratory Drug Delivery - PULMONOLOGY 2026 (France)
- Respiratory Infections - PULMONOLOGY 2026 (France)
- Respiratory Tract Infections - Copd 2026 (France)
- Severe Asthma Therapies - PULMONOLOGY 2026 (France)
- Sleep & Breathing Disorders - PULMONOLOGY 2026 (France)
- Stages & Severity on Lung Diseases - Copd 2026 (France)
- Thoracic Surgery Advances - PULMONOLOGY 2026 (France)
